Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Clene Inc.
CLNN
Healthcare
Biotechnology
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NDAQ:CLNN)
New Post
View:
Posts & Comments
Threaded Posts
(271)
•••
whytestocks
X
Post by
whytestocks
on Nov 13, 2024 9:15pm
Clene Reports Third Quarter 2024 Financial Results and Recen
Just In: $CLNN Clene Reports Third Quarter 2024 Financial Results and Recent Operating HighlightsClene met with the U.S. Food and Drug Administration (FDA) on November 1, 2024, in a Type C meeting to
...more
(271)
•••
whytestocks
X
Post by
whytestocks
on Oct 28, 2024 4:20pm
(CLNN) Technical Pivots with Risk Controls
NEWS: $CLNN (CLNN) Technical Pivots with Risk Controls2024-10-28 15:52:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to
...more
Redefining Neuroprotection: Revive’s Approach to Treating Brain Injury from Nerve Agents
posted Dec 03, 2024 9:00am by
Revive Therapeutics Ltd
-
|
Evaluating Bucillamine as a potential treatment for nerve agent exposure, in partnership with Defence R&D Canada – Suffield Research Centre (“DRDC”), an agency of the Canadian Department of National Defence. The DRDC is investigating pharmacological compounds, including Bucillamine, that can mitigate nerve agent induced brain injury. ...read more
(271)
•••
whytestocks
X
Post by
whytestocks
on Oct 18, 2024 3:15pm
Clene Inc. (NASDAQ: CLNN) Presents Lead Candidate CNM-Au8(R)
JUST IN: $CLNN Clene Inc. (NASDAQ: CLNN) Presents Lead Candidate CNM-Au8(R) Updates, Latest Achievements at Top Investor ConferencesClene gave a fireside presentation and held one-on-one investor
...more
(271)
•••
whytestocks
X
Post by
whytestocks
on Oct 02, 2024 2:30pm
InvestorNewsBreaks - Clene Inc. (NASDAQ: CLNN) Closes on Dir
Just In: $CLNN InvestorNewsBreaks - Clene Inc. (NASDAQ: CLNN) Closes on Direct Offering, Concurrent Private Placements Totaling $7.3MClene (NASDAQ: CLNN) , a late clinical-stage biopharmaceutical
...more
(271)
•••
whytestocks
X
Post by
whytestocks
on Sep 30, 2024 5:32pm
Clene Announces $7.3 Million Registered Direct Offering and
Just In: $CLNN Clene Announces $7.3 Million Registered Direct Offering and Concurrent Private Placements Priced at Market Under Nasdaq RulesSALT LAKE CITY, Sept. 30, 2024 (GLOBE NEWSWIRE) -- Clene Inc
...more
(271)
•••
whytestocks
X
Post by
whytestocks
on Sep 06, 2024 9:47pm
Clene Inc. (NASDAQ: CLNN) Seeks to Transform Neurodegenerati
BREAKING NEWS: $CLNN Clene Inc. (NASDAQ: CLNN) Seeks to Transform Neurodegenerative Disorder Treatments, with Rise in Prevalence and Associated MarketsWith a focus on improving mitochondrial health
...more
(271)
•••
whytestocks
X
Post by
whytestocks
on Aug 07, 2024 11:17pm
Clene Reports Second Quarter 2024 Financial Results and Rece
News; $CLNN Clene Reports Second Quarter 2024 Financial Results and Recent Operating HighlightsSurvival analyses with CNM-Au8 ® 30 mg treatment compared to matched PRO-ACT controls
...more
(59)
•••
Nibinator
X
Post by
Nibinator
on Jul 11, 2024 12:23pm
BUY BUY BUY BUY BUY
Day after r.s. promissing conjoncture
(271)
•••
whytestocks
X
Post by
whytestocks
on Jul 05, 2024 2:15pm
Clene Inc. (NASDAQ: CLNN) Presents Promising Preliminary Dat
Breaking News: $CLNN Clene Inc. (NASDAQ: CLNN) Presents Promising Preliminary Data on CNM-Au8(R) for Rett Syndrome TreatmentClene revealed new preliminary data on CNM-Au8 for Rett Syndrome treatment
...more
(271)
•••
whytestocks
X
Post by
whytestocks
on Jun 18, 2024 2:15pm
Clene Inc. (NASDAQ: CLNN) CEO and CFO Present Corporate Upda
BREAKING NEWS: $CLNN Clene Inc. (NASDAQ: CLNN) CEO and CFO Present Corporate Updates and Future Plans at 72nd Emerging Growth ConferenceClene@s CEO Rob Etherington and CFO Morgan Brown presented
...more
(271)
•••
whytestocks
X
Post by
whytestocks
on Feb 13, 2024 1:30pm
Clene Inc. (NASDAQ: CLNN) Revolutionizes Approach to Restore
JUST IN: $CLNN Clene Inc. (NASDAQ: CLNN) Revolutionizes Approach to Restore Neuronal Health in Neurodegenerative Disease with CNM-Au8(R)Neurodegenerative diseases pose a significant challenge in
...more
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
ReGen III Appoints New CEO and President to Accelerate Commercial and Strategic Opportunities
Introducing the NEW DealRoom: Your Gateway to Capital-Raising Investments
Debt-Free Cannabis Company Set for Next Stage of Growth
Learn How this Company is Disrupting Point-of-Care Testing
Unique Battery Metals opportunity in Quebec
Discover Options Trading Strategies to Minimize your Tax Burden
Rig Count Soars as Utilization Surpasses Industry Averages